SPONTANEOUS CHOROIDAL HEMORRHAGE IN A PATIENT ON DABIGATRAN ETEXILATE (PRADAXA)

    loading  Checking for direct PDF access through Ovid

Abstract

Purpose:

To report the first known case of spontaneous choroidals in association with a patient on dabigatran etexilate.

Methods:

Observational case report.

Results:

An 82-year-old man on 150 mg dabigatran etexilate by mouth twice a day for atrial fibrillation developed spontaneous choroidal hemorrhage in his left eye. No other causes were found after careful history and examination.

Conclusion:

Dabigatran is a popular new alternative to warfarin that has no blood monitoring or reversal agent. Physicians should be aware of this new medication and its possible hemorrhagic complications.

Related Topics

    loading  Loading Related Articles